BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34996395)

  • 1. A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.
    Chen MT; Pan F; Chen YC; Zhang W; Lv HJ; Wang Z; Hong HM; Fang XJ; Wang YW; Pan T; Zou LQ; Guo HQ; Xie K; Chen LM; Li XQ; Yao YY; Chen ZG; Weng HW; Li XD; Shen YY; Zhou H; Xue HW; Zhang HL; Huang H; Lin TY
    BMC Cancer; 2022 Jan; 22(1):45. PubMed ID: 34996395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
    Kim HD; Cho H; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Kim SJ; Ko YH; Kim WS; Suh C
    Cancer Res Treat; 2021 Jul; 53(3):847-856. PubMed ID: 33332932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocyte to monocyte ratio identifies high-risk adult patients with sporadic Burkitt lymphoma.
    Wang L; Wang H; Xia ZJ; Huang HQ; Jiang WQ; Lin TY; Lu Y
    Ann Hematol; 2015 Oct; 94(10):1645-54. PubMed ID: 26082333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.
    Wang F; Chen L; Wang Z; Xu Q; Huang H; Wang H; Li X; Yu M; Chen J; Lin F; Chen Z; Zhang X; Yang Q; Mou Y; Guo C
    Cancer Cell Int; 2022 Oct; 22(1):320. PubMed ID: 36242047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
    Sýkorová A; Procházka V; Móciková H; Janíková A; Pytlík R; Belada D; Benešová K; Klener P; Ďuraš J; Smolej L; Campr V; Blahovcová P; Trněný M
    Neoplasma; 2022 Dec; 69(6):1466-1473. PubMed ID: 36591807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of p-AKT and p-mTOR in pediatric Burkitt lymphoma and their correlation with prognosis].
    Man J; Chen L; Zhai XW; Ma YY; Wang HS; Qian XW; Feng JY; Zhao J; Cao P; Lu FJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):156-161. PubMed ID: 32074729
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children.
    Li J; Zhai XW; Wang HS; Qian XW; Miao H; Zhu XH
    Med Sci Monit; 2016 Dec; 22():4992-5002. PubMed ID: 27991481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkitt Lymphoma International Prognostic Index.
    Olszewski AJ; Jakobsen LH; Collins GP; Cwynarski K; Bachanova V; Blum KA; Boughan KM; Bower M; Dalla Pria A; Danilov A; David KA; Diefenbach C; Ellin F; Epperla N; Farooq U; Feldman TA; Gerrie AS; Jagadeesh D; Kamdar M; Karmali R; Kassam S; Kenkre VP; Khan N; Kim SH; Klein AK; Lossos IS; Lunning MA; Martin P; Martinez-Calle N; Montoto S; Naik S; Palmisiano N; Peace D; Phillips EH; Phillips TJ; Portell CA; Reddy N; Santarsieri A; Sarraf Yazdy M; Smeland KB; Smith SE; Smith SD; Sundaram S; Zayac AS; Zhang XY; Zhu C; Cheah CY; El-Galaly TC; Evens AM
    J Clin Oncol; 2021 Apr; 39(10):1129-1138. PubMed ID: 33502927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term retrospective study on sporadic Burkitt lymphoma in chinese population.
    Yang X; Huang Q; Li A; Chen Y; Xu W; Li J; Wang Y; Fang Y
    Medicine (Baltimore); 2020 Jan; 99(5):e18438. PubMed ID: 32000356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world outcomes of AIDS-related Burkitt lymphoma: a retrospective study of 78 cases over a 10-year period.
    Wang Z; Zhang R; Gong Z; Liu L; Shen Y; Chen J; Qi T; Song W; Tang Y; Sun J; Lin Y; Xu S; Yang J; Lu H
    Int J Hematol; 2021 Jun; 113(6):903-909. PubMed ID: 33594656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma.
    Yue W; Liu B; Gao L; He M; Wang J; Zhang W; Chen L; Hu X; Xu L; Yang J
    Clin Chim Acta; 2018 Oct; 485():316-322. PubMed ID: 30006285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
    Evens AM; Danilov A; Jagadeesh D; Sperling A; Kim SH; Vaca R; Wei C; Rector D; Sundaram S; Reddy N; Lin Y; Farooq U; D'Angelo C; Bond DA; Berg S; Churnetski MC; Godara A; Khan N; Choi YK; Yazdy M; Rabinovich E; Varma G; Karmali R; Mian A; Savani M; Burkart M; Martin P; Ren A; Chauhan A; Diefenbach C; Straker-Edwards A; Klein AK; Blum KA; Boughan KM; Smith SE; Haverkos BM; Orellana-Noia VM; Kenkre VP; Zayac A; Ramdial J; Maliske SM; Epperla N; Venugopal P; Feldman TA; Smith SD; Stadnik A; David KA; Naik S; Lossos IS; Lunning MA; Caimi P; Kamdar M; Palmisiano N; Bachanova V; Portell CA; Phillips T; Olszewski AJ; Alderuccio JP
    Blood; 2021 Jan; 137(3):374-386. PubMed ID: 32663292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
    Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
    Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
    Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.